Melevodopa
Melevodopa (brand name Levomet) is a dopaminergic agent. It is the methyl ester of levodopa. It is used in tablet form as an effervescent prodrug with 250 times the water solubility of tablet levodopa.[1]
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C10H13NO4 |
Molar mass | 211.217 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
See also
- Etilevodopa
References
- Hickey P, Stacy M (2011). "Available and emerging treatments for Parkinson's disease: a review". Drug Design, Development and Therapy. 5: 241–54. doi:10.2147/DDDT.S11836. PMC 3096539. PMID 21607020.
Antiparkinson agents (N04) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Dopaminergics |
| ||||||||||
Anticholinergics |
| ||||||||||
Others | |||||||||||
|
D1-like |
| ||||||
---|---|---|---|---|---|---|---|
D2-like | |||||||
|
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.